I do like alternative potential revenue options - when this one becomes reality, you then have a strong possibility of creating momentum.
These are substantial markets BOT is entering into, this cannot be done in 5 minutes on a shoestring budget. They wisely raised capital to keep the development program on track. Sure the sp took a hit, but you cannot have it both ways.
There is a big prize waiting down the road!
Ann: Ethics Approval for BTX 1308 Psoriasis Patient Study Secured, page-13
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.8¢ |
Change
-0.008(2.11%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.5¢ | $520.2K | 1.479M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 352594 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 219545 | 7 |
View Market Depth
| Last trade - 12.51pm 27/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
